河北医科大学学报

• 论著 • 上一篇    下一篇

双水平正压通气对难治性高血压合并阻塞性睡眠呼吸暂停综合征患者血压水平的影响

  

  1. 1.中国人民解放军总医院心内科,北京 100011;2.中国人民解放军海军总医院耳鼻喉科,北京 100048
  • 出版日期:2018-10-25 发布日期:2018-09-27
  • 作者简介:卢旭(1984-),男,吉林长春人,中国人民解放军总医院主治医师,医学硕士,从事心血管内科疾病诊治研究。

Effect of bilevel positive pressure ventilation on blood pressure in patients with refractory hypertension complicated with obstructive sleep apnea#br#

  1. 1.Department of Cardiology, General Hospital of Chinese People′s Liberation Army, Beijing
    100011, China; 2.Department of Otorhinolaryngology, Navy General Hospital of
    Chinese People′s Liberation Army, Beijing 100048, China
  • Online:2018-10-25 Published:2018-09-27

摘要: [摘要]〓
〖HTH〗目的〖HTSS〗〖KG*2〗观察应用双水平正压通气对难治性高血压合并阻塞性睡眠呼吸暂停综合征患者血压的影响。
〖HTH〗方法〖HTSS〗〖KG*2〗选取难治性高血压合并阻塞性睡眠呼吸暂停综合征患者114例,试验前测定卧位血浆肾素、血管紧张素Ⅱ、醛固酮水平、24 h动态血压、多导睡眠监测、呼吸暂停低通气指数、最低血氧饱和度,给予每晚不少于6 h的双水平正压通气治疗,随访6个月复测上述指标与试验前进行比较。
〖HTH〗结果〖HTSS〗〖KG*2〗治疗后6个月呼吸暂停低通气指数、血氧饱和度<90%百分比均低于治疗前,最低血氧饱和度、平均血氧饱和度高于治疗前(P<0.05);治疗后24 h收缩压及24 h舒张压、日间收缩压、日间舒张压、夜间收缩压和夜间舒张压较治疗前降低((P<0.05);治疗后24 h收缩压变异性、24 h舒张压变异性、日间收缩压变异性、日间舒张压变异性、夜间收缩压变异性和夜间舒张压变异性较治疗前降低(P<0.05);治疗后肾素、血管紧张素Ⅱ、醛固酮水平较治疗前降低(P<005)。
〖HTH〗结论〖HTSS〗〖KG*2〗对难治性高血压合并阻塞性睡眠呼吸暂停综合征患者,在药物治疗的基础上进行6个月双水平正压通气能有效降低24 h、白昼、夜间收缩压及舒张压水平,并可降低血压变异性,为治疗难治性高血压合并阻塞性睡眠呼吸暂停综合征患者血压控制的有效措施。

关键词: 高血压, 睡眠呼吸暂停, 阻塞性, 多导睡眠描记术

Abstract: [Abstract] Objective〖HTSS〗〓To study the effect of bilevel positive pressure ventilation on blood pressure in patients with refractory hypertension complicated with obstructive sleep apnea syndrome.
〖HTH〗〖WTHZ〗Methods〖HTSS〗〓A total of 114 patients with resistant hypertension combined with obstructive sleep apnea hypopnea syndrome were selected. The levels of renin, angiotensin Ⅱ, aldosterone, 24hour ambulatory blood pressure, multiple sleep monitoring, apnea hypopnea index, and minimum oxygen saturation were measured before the trial. Then each subject was given a bilevel positive pressure ventilation treatment for at least 6 hours every evening. Patients were followed up for 6 months. After the trial the levels of renin, angiotensin Ⅱ, aldosterone, 24 hour ambulatory blood pressure, multiple sleep monitoring, apnea hypopnea index, and minimum oxygen saturation were measured in the patients again . After followup for 6 months, the above indicators were compared with those before the trial.
〖HTH〗〖WTHZ〗Results〖HTSS〗〓After 6 months bilevel positive pressure ventilation the apnea hypopnea index and oxygen saturation<90% were lower than before, and minimum oxygen saturation and mean oxygen saturation were uppered. The difference was statistically significant(P<005). Systolic blood pressure and diastolic blood pressure in 24 h, systolic blood pressure and diastolic blood pressure in daytime, systolic blood pressure and diastolic blood pressure at night were compared with those before treatment, all were lowered, and the difference was statistically significant(P<005). The blood pressure variability was reduced after the treatment, compared to that before the trial, the difference was statistically significant(P<005). The levels of renin, angiotensin Ⅱ, aldosterone were also decreased compared with those before treatment. And the difference was statistically significant(P<005).
〖HTH〗〖WTHZ〗Conclusion〖HTSS〗〓In patients with resistant hypertension combined with obstructive sleep apnea hypopnea syndrome, a bilevel positive pressure ventilation treatment based on drug therapy for 6 months can effectively control the patients' blood pressure.

Key words: hypertension, sleep apnea, obstructive, polysomnography